Has anyone done any research on why Cheng Liu has listed an entirely new company, "Estrella Biopharma", and seemingly basing its core technology off of our Eureka collaboration (ARTEMIS+ONCARLYTICS)? And does IMU own any part of this new company?
Ann: Imugene onCARlytics with Estrella ARTEMIS T Cells SITC, page-41
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.001(1.11%) |
Mkt cap ! $331.0M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.4¢ | $355.8K | 7.920M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 5890763 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 1009158 | 19 |
View Market Depth
| Last trade - 15.25pm 07/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |